EMA Calls For Visual Warnings Among Measures To Restrict Valproate Use
The European Medicines Agency has recommended that EU member states should introduce further restrictions on the use of valproate-containing medicines to avoid the drug's exposure in pregnancy.
You may also be interested in...
The French health authorities are looking more widely at the actual or potential risks of using anti-epileptic medicines in pregnancy or in women of child bearing age. Valproate is a particular focus, but other drugs like topiramate and pregabalin are also in the frame.
Sanofi is working on technical improvements after its Mourenx site in southwest France was found to be emitting illegally high levels of solvents. Production at the site is on hold.
At the European Medicines Agency's second ever public hearing on the safety of marketed medicines, patients gave an emotional account of how they battled with 'ignorance' within the EU medical community about the severely debilitating and potentially permanent side-effects of some broad-spectrum antibiotics.